Skip to main content

JANE STREET GROUP, LLC

Position in TRDA — Entrada Therapeutics, Inc.

CIK 1595888 NEW YORK, NY

Position in TRDA

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$469,627
-$410,977 QoQ
Shares Held
37,213
-56.6% QoQ
Ownership
0.096%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2022
8 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TRDA Over Time

Shares Held

Position Value (USD)

Derivatives in TRDA

reported options exposure · as of Dec 31, 2025
CallValue
$0
CallShares
0
PutValue
$113,080
PutShares
11,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JANE STREET GROUP, LLC holds $1,364,130,252 across 291 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in TRDA

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $469,627 37,213
2025-12-31 $880,604 85,662
2025-12-31 $113,080 11,000
2025-09-30 $1,435,592 247,516
2025-06-30 $343,780 51,158
2024-09-30 $247,913 15,514
2024-06-30 $381,243 26,754
2023-03-31 $1,071,521 73,898
2022-12-31 $196,364 14,524